You need to login...
If you are not registered...
| Subscribe to Krixos Health: | |
|
or call us on: +43 (0)1 27 63 015 or email: subscribe@krixos.com |
|
Most viewed
- 1. Thousands of blood cancer patients could benefit from new drug combination
- 2. Targeted cancer drugs may replace chemo for some patients — and drugmakers say they're getting closer
- 3. Clarity enters a Commercial Manufacturing Agreement for Cu-64 SAR-bisPSMA with SpectronRx
- 4. Diagnostic value of [18F]PSMA-1007 PET/CT based on PRIMARY score combined with mpMRI in clinically significant prostate cancer
- 5. Update in the clinical utilization of chemoprevention for breast cancer: a narrative review
- 6. Neutrophil extracellular traps and cannabinoids: potential in cancer metastasis
- 7. Research progress and molecular mechanism of oridonin in the treatment of malignant melanoma
- 8. Effects of gut microbiota in breast cancer
- 9. Abemaciclib treatment patterns and outcome in HR+/HER2- locally advanced or metastatic breast cancer: a real-world study from Kuwait and Lebanon
- 10. Eli Lilly looks beyond its blockbuster obesity drugs with another smart deal
Last updated at 13:07 GMT
Hot News Makers
Health/Pharma Companies
-
52224.96
-
46601.47
-
38822.78
-
15132.78
-
11029.85
-
10263.89
-
9399.93
-
9392.94
-
9237.50
-
6894.44
Drugs, Treatments, Trials
-
35045.37
-
21526.87
-
19509.60
-
16654.91
-
12979.77
-
11481.00
-
5736.03
-
4552.24
-
4438.08
-
2570.44
Last updated at 12:10 GMT
